Searched for
SUVEN PHARMA FDI INVESTMENT
Indian economy remains exposed to energy price shocks: RBI reportIndia's economy faces potential exchange rate volatility due to rising oil prices and supply chain issues, an RBI report revealed. Despite ...- US-Iran thaw to provide tailwinds for growth: RBIIndia's economic growth could get a boost from the Iran-US peace deal, according to the Reserve Bank's latest report. While the economy sho...
- Two general insurance licences approved since 100% FDI move by govt: Irdai chairman Ajay SethIndia's insurance regulator has greenlit two proposals for 100% foreign ownership in general insurance firms, following the government's FD...
- Delayed monsoon may weigh on auto demand, but long-term outlook stays strong: Aditya ShahA delayed monsoon poses a temporary challenge to rural auto demand, particularly for tractors and two-wheelers, but the sector's long-term ...
- Zee Entertainment gets govt nod for Rs 418-cr investment from Invesco fundZee Entertainment has secured a significant Rs 418 crore foreign investment from OFI Global China Fund LLC, marking the fund's return after...
- Market wrap: Sensex falls 372 points, Nifty closes below 23,950; Kotak Mahindra Bank drops 3%Indian markets ended lower as Sensex and Nifty snapped a two-session winning streak, pressured by geopolitical tensions in the Middle East ...
- 2 top stock recommendations from Vinay RajaniIndian equity markets are experiencing a cautious phase, consolidating within a defined range as fresh buying momentum remains elusive. Tec...
- Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
- Nifty has more room to run; stay selective: AnalystsIndian stock markets are showing cautious optimism, with the Nifty eyeing the 24,300-25,000 zone amid ongoing volatility. Analysts recommen...
- Easing of West Asia conflict reduces downside risk to 6.6% growth forecast: Ram Singh, Director, Delhi School of EconomicsAny moderation in El Nino effects and resolution of geopolitical uncertainty will further reduce the downside risks to growth. Operationali...
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
- Strides Pharma sells majority stake in arm Pivot Path for Rs 100 croreStrides Pharma Science has divested a majority stake in its subsidiary, Pivot Path, for Rs 100 crore to a consortium led by Ascent Capital ...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- Domestic SIPs power India's market resilience amidst FPI outflows: HDFC SecuritiesIndia is experiencing a pivotal shift in its financial markets as domestic investors take the lead over foreign entities, enduring a three-...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Ahead of Market: 10 things that will decide stock market action on WednesdaySensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. ...
- Chinese tech, investments welcome, but trade opening needs caution: CII PresidentChinese investments and technology are welcome in India, but a cautious approach is needed for trade, according to CII President R Mukundan...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- How India can win in a rewired global economyIndia is poised to gain from global supply chain shifts. Strategic neutrality and domestic focus are key. The nation must build robust buff...
Load More
